Comprehensive care programme for patients with chronic obstructive pulmonary disease: A randomised controlled trial

Thorax

Volumn 72, Issue 2, 2017, Pages 122-128

  Ko, Fanny W S ^a   Cheung, N K ^a   Rainer, Timothy H ^a   Lum, Christopher ^b   Wong, Ivor ^c   Hui, David S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHATIN HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPREHENSIVE CARE PROGRAM; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NURSE; PATIENT EDUCATION; PERSONALIZED MEDICINE; PHYSIOTHERAPIST; PHYSIOTHERAPY; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TELECONSULTATION; HOSPITALIZATION; INTEGRATED HEALTH CARE SYSTEM; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84979702205     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208396     Document Type: Article

References (45)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
2. Ko FW, Hui DS, Lai CK. Worldwide burden of COPD in high-and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis 2008;12:713-17.
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Updated 2015. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2015-Apr2.pdf (last assessed 12 Jun 2015).
4. Chan-Yeung M, Lai CK, Chan KS, et al. The burden of lung disease in Hong Kong: a report from the Hong Kong Thoracic Society. Respirology 2008;13(Suppl 4): S133-65.
5. Britton M. The burden of COPD in the UK: results from the Confronting COPD survey. Respir Med 2003;97(Suppl C):S71-9.
6. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
7. Donaldson GC, Seemungal T, Jeffries DJ, et al. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 1999;13:844-9.
8. Davies L, Wilkinson M, Bonner S, et al. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000;321:1265-8.
9. Shepperd S, Iliffe S. Hospital at home versus in-patient hospital care. Cochrane Database Syst Rev 2001;(3):CD000356.
10. Sridhar M, Taylor R, Dawson S, et al. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax 2008;63:194-200.
11. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585-91.
12. Martin IR, McNamara D, Sutherland FR, et al. Care plans for acutely deteriorating COPD: a randomized controlled trial. Chron Respir Dis 2004;1:191-5.
13. Adams SG, Smith PK, Allan PF, et al. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med 2007;167:551-61.
14. Littlejohns P, Baveystock CM, Parnell H, et al. Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation. Thorax 1991;46:559-64.
15. Cockcroft A, Bagnall P, Heslop A, et al. Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br Med J (Clin Res Ed) 1987;294:225-8.
16. Pushparajah S, McClellan R, Henry A, et al. Use of a chronic disease management programme in COPD to reduce hospital admissions. Chron Respir Dis 2006;3:187-93.
17. Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013;10:CD009437.
18. Ko FW, Dai DL, Ngai J, et al. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology 2011;16:617-24.
19. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;3: CD002990.
20. Ko FW, Ngai JC, Ng SS, et al. COPD care programme can reduce readmissions and in-patient bed days. Respir Med 2014;108:1771-8.
21. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64.
22. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
23. Ip MS, Ko FW, Lau AC, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest 2006;129:384-92.
24. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
25. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
26. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
27. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-9.
28. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006;28:123-30.
29. Harrison SL, Janaudis-Ferreira T, Brooks D, et al. Self-management following an acute exacerbation of COPD: a systematic review. Chest 2015;147:646-61.
30. Puhan MA, Gimeno-Santos E, Scharplatz M, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(10):CD005305.
31. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in adults quality statement 5: Pulmonary rehabilitation after an acute exacerbation. Published date: July 2011. Last updated: February 2016. https://www. nice.org.uk/guidance/qs10/chapter/quality-statement-5-pulmonary-rehabilitationafter-an-acute-exacerbation (last assessed 23 Apr 2016).
32. Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013;68(Suppl 2): 1-30.
33. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64.
34. Harrison SL, Robertson N, Graham CD, et al. Can we identify patients with different illness schema following an acute exacerbation of COPD: a cluster analysis. Respir Med 2014;108:319-28.
35. Maddocks M, Kon SS, Singh SJ, et al. Rehabilitation following hospitalization in patients with COPD: can it reduce readmissions Respirology 2015;20:395-404.
36. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
37. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010;16:97-105.
38. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.
39. Kruis AL, Boland MR, Assendelft WJ, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ 2014;349:g5392.
40. Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012;156:673-83.
41. Jennings JH, Thavarajah K, Mendez MP, et al. Predischarge Bundle for Patients With Acute Exacerbations of COPD to Reduce Readmissions and ED Visits: A Randomized Controlled Trial. Chest 2015;147:1227-34.
42. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management, NICE guidelines [CG101]. 2010. https://www.nice.org.uk/guidance/cg101 (last assessed 23 Apr 2016).
43. Yu WC, Tai EL, Fu SN, et al. Treatment of patients with chronic obstructive pulmonary disease as practised in a defined Hong Kong community: a cross-sectional pilot survey. Hong Kong Med J 2011;17:306-14.
44. Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis 2014;9:889-904.
45. Adamson SL, Burns J, Camp PG, et al. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 2016;11:61-71.